Gen Surg Cases · vascular
Active venous ulcer with superficial-plus-segmental-deep reflux — stratum, timing, and staying healed
Fellowship clinical-management station on active venous ulceration with superficial-plus-segmental-deep reflux: ESCHAR stratum-specific recurrence counselling, EVRA early-ablation timing, concomitant tributary planning, compression-system choice, and recurrence-prevention cover.
On this page
Study tools
Target exams
Candidate tasks and model management
Stratify her deep reflux before promising anything. She sits in the segmental-deep stratum — not isolated superficial, not total deep — so quote the stratum-specific dividend: at 3 years recurrence runs 52 versus 24% with added surgery (P=0.04), matching the isolated-superficial dividend (51 vs 27% at 4 years), while total deep reflux dissolves it (46 vs 32% ns).[10] Confirm the pattern on duplex of the ulcerated leg — ESCHAR imaged 500 consecutive legs this way — and note surgery abolished segmental deep reflux in 10 of 22 such legs.[9][11]
Reconcile healing with recurrence honestly. Tell her surgery does not hasten healing — 24-week healing tied 65 versus 65%, 3-year tied 89 versus 93% — but halves 12-month recurrence (12 vs 28%) and buys ulcer-free time (78 vs 71% at 3 years).[9][10] Then offer speed through early ablation: within 2 weeks of randomisation, healing hazard 1.38 with median 56 against 82 days and 24-week healing 85.6 against 76.3%.[12]
Plan tributaries and compression in the same sitting. Treat tributaries concomitantly — 6 randomised trials, reintervention cut to one-third with no safety penalty — and set expectations with the Marston arc: 57/74/78% healed at 3/6/12 months with recurrence at 9/20/29% across 1–3 years, worsened by deep insufficiency and skipped phlebectomy.[26][32] Bandage to heal by tolerance — 21 trials show no system heals meaningfully faster, with four-layer-or-hosiery cost-effective — then convert the healed leg to stockings: European class-3 halves reulceration against none and class-3 beats class-2.[35][34] Cover high-thrombosis-risk legs with 1–2 weeks of low-molecular-weight heparin by consensus rather than a single dose.[37]
References9ShowHide
- [9]Barwell JR, et al. Comparison of surgery and compression with compression alone in chronic venous ulceration (ESCHAR study): randomised controlled trial. Lancet, 2004.PMID 15183623
- [10]Gohel MS, et al. Long term results of compression therapy alone versus compression plus surgery in chronic venous ulceration (ESCHAR): randomised controlled trial. BMJ, 2007.PMID 17545185
- [11]Gohel MS, et al. Randomized clinical trial of compression plus surgery versus compression alone in chronic venous ulceration (ESCHAR study)--haemodynamic and anatomical changes. Br J Surg, 2005.PMID 15584055
- [12]Gohel MS, et al. A Randomized Trial of Early Endovenous Ablation in Venous Ulceration. N Engl J Med, 2018.PMID 29688123
- [26]Xie Y, et al. Combined endovenous ablation with phlebectomy or foam sclerotherapy versus endovenous ablation alone for lower limb varicose veins: A systematic review and meta-analysis. Phlebology, 2026.PMID 41990331
- [35]Phung H, et al. Compression systems for venous leg ulcers: a network meta-analysis and cost-effectiveness analysis. EClinicalMedicine, 2026.PMID 42518940
- [34]de Moraes Silva MA, et al. Compression for preventing recurrence of venous ulcers. Cochrane Database Syst Rev, 2024.PMID 38451842
- [32]Marston WA, et al. Incidence of venous leg ulcer healing and recurrence after treatment with endovenous laser ablation. J Vasc Surg Venous Lymphat Disord, 2017.PMID 28623990
- [37]Dattani N, et al. Reducing the risk of venous thromboembolism following superficial endovenous treatment: A UK and Republic of Ireland consensus study. Phlebology, 2020.PMID 32611228